ASX - By Stock
|
PAR |
Re:
Ann: iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS
|
|
Wwend
|
237 |
75K |
13 |
14/10/23 |
14/10/23 |
ASX - By Stock
|
237
|
75K
|
13
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS
|
|
Wwend
|
237 |
75K |
5 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
237
|
75K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Wwend
|
670 |
258K |
8 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
670
|
258K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Primary and Secondary endpoints met in MPS I Trial
|
|
Wwend
|
37 |
20K |
0 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
37
|
20K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Primary and Secondary endpoints met in MPS I Trial
|
|
Wwend
|
37 |
20K |
0 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
37
|
20K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Wwend
|
670 |
258K |
3 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
670
|
258K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Wwend
|
4.3K |
1.9M |
2 |
25/04/23 |
25/04/23 |
ASX - By Stock
|
4.3K
|
1.9M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Wwend
|
4.3K |
1.9M |
1 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
4.3K
|
1.9M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Wwend
|
4.3K |
1.9M |
1 |
03/01/23 |
03/01/23 |
ASX - By Stock
|
4.3K
|
1.9M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Wwend
|
4.3K |
1.9M |
0 |
03/01/23 |
03/01/23 |
ASX - By Stock
|
4.3K
|
1.9M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Wwend
|
4.3K |
1.9M |
8 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
4.3K
|
1.9M
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Competition???
|
|
Wwend
|
61 |
25K |
0 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
61
|
25K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Reports Australian Patent Acceptance
|
|
Wwend
|
64 |
24K |
1 |
01/07/22 |
01/07/22 |
ASX - By Stock
|
64
|
24K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Wwend
|
4.3K |
1.9M |
4 |
19/06/22 |
19/06/22 |
ASX - By Stock
|
4.3K
|
1.9M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Wwend
|
4.3K |
1.9M |
0 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
4.3K
|
1.9M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Wwend
|
4.3K |
1.9M |
1 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
4.3K
|
1.9M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Wwend
|
4.3K |
1.9M |
1 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
4.3K
|
1.9M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
MOZZ Research - First Half 2021
|
|
Wwend
|
52 |
16K |
0 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
52
|
16K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Wwend
|
4.2K |
3.8M |
0 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
4.2K
|
3.8M
|
0
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Update on MRSA Analysis Module US FDA Submission
|
|
Wwend
|
17 |
9.1K |
1 |
25/11/20 |
25/11/20 |
ASX - By Stock
|
17
|
9.1K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Letter to Shareholders - AGM
|
|
Wwend
|
4 |
2.8K |
0 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
4
|
2.8K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Wwend
|
13K |
4.9M |
0 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
13K
|
4.9M
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
Wwend
|
13K |
4.9M |
1 |
20/10/20 |
20/10/20 |
ASX - By Stock
|
13K
|
4.9M
|
1
|
|
ASX - By Stock
|
PAR |
Re:
PPS trials
|
|
Wwend
|
29 |
13K |
13 |
16/10/20 |
16/10/20 |
ASX - By Stock
|
29
|
13K
|
13
|
|
ASX - By Stock
|
PAR |
Re:
A little taste before mains?
|
|
Wwend
|
44 |
18K |
2 |
23/07/20 |
23/07/20 |
ASX - By Stock
|
44
|
18K
|
2
|
|
ASX - By Stock
|
LBT |
Re:
today's presentation
|
|
Wwend
|
6 |
3.0K |
1 |
27/05/20 |
27/05/20 |
ASX - By Stock
|
6
|
3.0K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Who are we?
|
|
Wwend
|
121 |
53K |
0 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
121
|
53K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Who are we?
|
|
Wwend
|
121 |
53K |
0 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
121
|
53K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm receives clarity on US regulatory pathway
|
|
Wwend
|
55 |
23K |
2 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
55
|
23K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm receives clarity on US regulatory pathway
|
|
Wwend
|
55 |
23K |
13 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
55
|
23K
|
13
|
|
ASX - By Stock
|
PAR |
Re:
Media article before Ann
|
|
Wwend
|
37 |
14K |
2 |
06/04/20 |
06/04/20 |
ASX - By Stock
|
37
|
14K
|
2
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: AusCann to Commence Clinical Trial and Product Distribution
|
|
Wwend
|
64 |
28K |
1 |
02/04/20 |
02/04/20 |
ASX - By Stock
|
64
|
28K
|
1
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: CH2 appointed to distribute AusCann's products in Australia
|
|
Wwend
|
41 |
66K |
1 |
25/02/20 |
25/02/20 |
ASX - By Stock
|
41
|
66K
|
1
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: CH2 appointed to distribute AusCann's products in Australia
|
|
Wwend
|
41 |
66K |
1 |
24/02/20 |
24/02/20 |
ASX - By Stock
|
41
|
66K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
FiftyOne Capital
|
|
Wwend
|
80 |
57K |
0 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
80
|
57K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
TGA Provisional Approval...The Countdown is On!
|
|
Wwend
|
30 |
22K |
1 |
08/01/20 |
08/01/20 |
ASX - By Stock
|
30
|
22K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Valuation and Targets
|
|
Wwend
|
361 |
273K |
0 |
17/12/19 |
17/12/19 |
ASX - By Stock
|
361
|
273K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm End of Calendar Year Update
|
|
Wwend
|
73 |
37K |
0 |
12/12/19 |
12/12/19 |
ASX - By Stock
|
73
|
37K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm End of Calendar Year Update
|
|
Wwend
|
73 |
37K |
0 |
12/12/19 |
12/12/19 |
ASX - By Stock
|
73
|
37K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm End of Calendar Year Update
|
|
Wwend
|
73 |
37K |
0 |
12/12/19 |
12/12/19 |
ASX - By Stock
|
73
|
37K
|
0
|
|
ASX - By Stock
|
AC8 |
Re:
Whats on the menu today
|
|
Wwend
|
337 |
157K |
1 |
10/12/19 |
10/12/19 |
ASX - By Stock
|
337
|
157K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Long Term Holders...How Many Shares Are You Hoarding?
|
|
Wwend
|
162 |
86K |
1 |
02/12/19 |
02/12/19 |
ASX - By Stock
|
162
|
86K
|
1
|
|
ASX - By Stock
|
AC8 |
Re:
Ann: Pharmaceutical Packaging Agreement with Aspen Pharmacare
|
|
Wwend
|
62 |
25K |
4 |
27/11/19 |
27/11/19 |
ASX - By Stock
|
62
|
25K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Wwend
|
4.3K |
1.9M |
0 |
15/11/19 |
15/11/19 |
ASX - By Stock
|
4.3K
|
1.9M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Wwend
|
4.3K |
1.9M |
0 |
15/11/19 |
15/11/19 |
ASX - By Stock
|
4.3K
|
1.9M
|
0
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Wwend
|
4.3K |
1.9M |
0 |
13/11/19 |
13/11/19 |
ASX - By Stock
|
4.3K
|
1.9M
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Institutional Placement of A$120.0 Million
|
|
Wwend
|
124 |
122K |
0 |
13/11/19 |
13/11/19 |
ASX - By Stock
|
124
|
122K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Institutional Placement of A$120.0 Million
|
|
Wwend
|
124 |
122K |
2 |
13/11/19 |
13/11/19 |
ASX - By Stock
|
124
|
122K
|
2
|
|
ASX - By Stock
|
AC8 |
Re:
News: AC8 Auscann Group Holdings Says Mal Washer Retired As Chairman
|
|
Wwend
|
161 |
74K |
6 |
06/11/19 |
06/11/19 |
ASX - By Stock
|
161
|
74K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
The possible TGA Provisional Timetable
|
|
Wwend
|
67 |
32K |
5 |
06/11/19 |
06/11/19 |
ASX - By Stock
|
67
|
32K
|
5
|
|